Document Detail


Novel oral anticoagulants for atrial fibrillation.
MedLine Citation:
PMID:  23761015     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Three novel oral anticoagulants (NOACS)-dabigatran etexilate, rivaroxaban, and apixaban-have been approved in many countries for stroke prevention in atrial fibrillation, because they are associated with the same or lower rates of stroke, bleeding (particularly intracranially) and death compared with warfarin; and unlike warfarin, they can be given in fixed doses without routine coagulation monitoring. The effects of NOACs compared with warfarin are consistent in almost all populations and patient subgroups studied. Pharmacoeconomic analyses indicate that the NOACs are also cost-effective in Europe and North America. The lack of an antidote to the NOACs in patients who experience major bleeding has not been associated with a worse outcome among patients treated with NOACs compared with warfarin in secondary analyses. Multiple guidelines for the management of AF now recommend the NOACs for stroke prevention among atrial fibrillation (AF) patients at risk for stroke.
Authors:
Graeme J Hankey; John W Eikelboom
Related Documents :
3668975 - Clinical and genetic characteristics of upper gastrointestinal disease in rheumatoid ar...
12153345 - Occurrence of ulcerative oral lesions at kenyatta national hospital, nairobi, kenya.
4036945 - Physiopathological heterogeneity of the duodenal mechanisms that inhibit gastric acid s...
25083135 - Xantus: rationale and design of a noninterventional study of rivaroxaban for the preven...
9684915 - Neuropsychological impairment and psychopathology in first-episode schizophrenic patien...
8179975 - Hypokalaemia in the elderly: is it always diuretic-induced?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  15     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-06-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  344     Citation Subset:  IM    
Affiliation:
Stroke Unit, Department of Neurology, Royal Perth Hospital, 197 Wellington Street, Perth, Australia, graeme.hankey@uwa.edu.au.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Systematic review of telestroke for post-stroke care and rehabilitation.
Next Document:  11p13 deletions can be more frequent than the PAX6 gene point mutations in Polish patients with anir...